CHOLERA Vibrio cholerae Brenda Anna Kwambana Wangeci Kagucia.

21
CHOLERA Vibrio cholerae Brenda Anna Kwambana Wangeci Kagucia

Transcript of CHOLERA Vibrio cholerae Brenda Anna Kwambana Wangeci Kagucia.

Page 1: CHOLERA Vibrio cholerae Brenda Anna Kwambana Wangeci Kagucia.

CHOLERAVibrio cholerae

Brenda Anna Kwambana

Wangeci Kagucia

Page 2: CHOLERA Vibrio cholerae Brenda Anna Kwambana Wangeci Kagucia.

History

• Origins in India, cases reported as early as 1563• About 8 pandemics to date

– 1817-`23: First Pandemic– 1829-`50: Second Pandemic– 1852-`60: Third Pandemic* Pacini– 1863-`79: Fourth Pandemic– 1881-`96: Fifth Pandemic * Koch– 1899-`1923: Sixth Pandemic– 1961-?: Seventh Pandemic– 1992-?: Eighth Pandemic

Page 3: CHOLERA Vibrio cholerae Brenda Anna Kwambana Wangeci Kagucia.

History

• First pandemic spreads from India to South, Central Asia, Middle East and Russia

• Second pandemic reaches England• Pandemics in 1800’s deadly• All pandemics reach Africa• First pandemic reaches Latin America in

1991

Page 4: CHOLERA Vibrio cholerae Brenda Anna Kwambana Wangeci Kagucia.

Distribution

Page 5: CHOLERA Vibrio cholerae Brenda Anna Kwambana Wangeci Kagucia.

Causative AgentDiscovery

• 19th Century: What is Cholera?

• Miasma Theory

• Blood Generation Theory

• Germ Theory

Page 6: CHOLERA Vibrio cholerae Brenda Anna Kwambana Wangeci Kagucia.

Causative AgentDiscovery

• John Snow (1813-1858):

• Water borne transmission of Cholera (1855)

Page 7: CHOLERA Vibrio cholerae Brenda Anna Kwambana Wangeci Kagucia.

Discovery

• Filippo Pacini (1812-1883)– 1854: Cholera reaches

Florence, Italy. Pacini discovers causative agent

– Publishes “Microscopical Observations and Pathological Deductions on Cholera”

– 1965: Bacterium named Vibrio cholerae Pacini 1854

Page 8: CHOLERA Vibrio cholerae Brenda Anna Kwambana Wangeci Kagucia.

Discovery

• Robert Koch (1843-1910)

• 1884: Rediscovers Vibrio cholerae

Page 9: CHOLERA Vibrio cholerae Brenda Anna Kwambana Wangeci Kagucia.

Vibrio choleraeMorphology

• Gram negative

• Comma shaped

• Sheathed, polar flagellum

• 1.4-2.6µm x 0.5-3µm

Page 10: CHOLERA Vibrio cholerae Brenda Anna Kwambana Wangeci Kagucia.

Physiology

• Facultative anaerobic

• Asporogenous

• Growth stimulated by NaCl

• pH 6 - 10, Acid labile

• Temperature 18 - 37ºC

Page 11: CHOLERA Vibrio cholerae Brenda Anna Kwambana Wangeci Kagucia.

Virulence & PathogenicityIngestion of V. cholerae

Resistant to gastric acid

Colonize small intestine

Virulence of Non-toxigenic V. cholerae O1 strain not well understood

Page 12: CHOLERA Vibrio cholerae Brenda Anna Kwambana Wangeci Kagucia.

Toxigenic V. cholerae Pathogenicity

• Colonization factors (the TcpA pilus)

• Production of enterotoxin

• Associated outer membrane proteins on enterocytes e.g. adenylate cyclase

Page 13: CHOLERA Vibrio cholerae Brenda Anna Kwambana Wangeci Kagucia.

Secrete enterotoxin

Enterotoxin binds to intestinal cells

Chloride channels activated

Release Large quantities of electrolytes & bicarbonates

Fluid hypersecretion

Diarrhea

Dehydration

Page 14: CHOLERA Vibrio cholerae Brenda Anna Kwambana Wangeci Kagucia.

Transmission

• Fecal-oral route

• Entry = oral

• Discharge = fecal

Page 15: CHOLERA Vibrio cholerae Brenda Anna Kwambana Wangeci Kagucia.

Transmission

• Humans only reservoirs

• Bacterium transmitted via contaminated water, food

• Carriers: houseflies and other insects

• Person to person transmission?

Page 16: CHOLERA Vibrio cholerae Brenda Anna Kwambana Wangeci Kagucia.

Symptoms• 1-3 day Incubation Period

• Mild diarrhea Sudden severe diarrhea • Mucus and intestinal tissue visible in feces

• Muscle cramps

• Scaphoid abdomen

• Vomiting

• Loss of skin turgor

• Weak pulse

Page 17: CHOLERA Vibrio cholerae Brenda Anna Kwambana Wangeci Kagucia.

Diagnosis

• Clinical symptoms

• Isolation of V. cholerae from stool– Live V. cholerae in stool (ca. 1.0 x 108 cells per ml)– Identification via dark-field microscopy

• Measurement of serum antibodies using ELISA

– Antibacterial antibodies: vibriocidal assays

– Antitoxin antibodies

Page 18: CHOLERA Vibrio cholerae Brenda Anna Kwambana Wangeci Kagucia.

Methods of CureChemotherapeutic

• Antibiotics (tetracycline)

Immunological

• Local mucosal immune response to V. cholerae• Serological antivibrio antibodies• Antitoxin antibodies To Ease Symptoms

• Oral Rehydration• Intraveneous Rehydration

Page 19: CHOLERA Vibrio cholerae Brenda Anna Kwambana Wangeci Kagucia.

Prevention & Control• Immunization

– Active Immunity induced by:• attenuated V. cholerae• Toxoid (not good antigen)

• Preventing contamination of food and water e.g. boiling water, covering food

• Education– Personal and domestic hygiene

• Prevention of contamination of water supplies– Improvement of sewage systems

Page 20: CHOLERA Vibrio cholerae Brenda Anna Kwambana Wangeci Kagucia.

References

• Wachsmuth, I., Blake, P. & Olsvik. O (Eds.). Vibrio cholerae and Cholera: Molecular to Global Perspectives. Washington, DC: ASM Press (1994)

• Drasar, B., Forrest, B. (Eds). Cholera and the Ecology of Vibrio cholerae. Bury St Edmunds, Great Britain: Chapman & Hall (1996)

• Perry, J., Staley, J. & Lory, S. Microbial Life. Sunderland, MA: Sinauer Associates, Inc. (2002)

• US Food and Drug Administration. Vibrio cholerae Serogroup 01. Stable URL: “http://vm.cfsan.fda.gov/~MOW/chap7.html